- Home
- HBIO vs VRCA Comparison
HBIO vs VRCA Comparison
Compare HBIO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- VRCA
- Stock Information
- Founded
- HBIO 1901
- VRCA 2013
- Country
- HBIO United States
- VRCA United States
- Employees
- HBIO N/A
- VRCA N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- VRCA Health Care
- Exchange
- HBIO Nasdaq
- VRCA Nasdaq
- Market Cap
- HBIO 61.2M
- VRCA 58.0M
- IPO Year
- HBIO 2000
- VRCA 2018
- Fundamental
- Price
- HBIO $0.60
- VRCA $0.42
- Analyst Decision
- HBIO Buy
- VRCA Hold
- Analyst Count
- HBIO 1
- VRCA 5
- Target Price
- HBIO $4.50
- VRCA $6.00
- AVG Volume (30 Days)
- HBIO 366.5K
- VRCA 544.8K
- Earning Date
- HBIO 03-12-2025
- VRCA 03-11-2025
- Dividend Yield
- HBIO N/A
- VRCA N/A
- EPS Growth
- HBIO N/A
- VRCA N/A
- EPS
- HBIO N/A
- VRCA N/A
- Revenue
- HBIO $94,135,000.00
- VRCA $7,566,000.00
- Revenue This Year
- HBIO N/A
- VRCA $93.38
- Revenue Next Year
- HBIO $7.97
- VRCA $127.27
- P/E Ratio
- HBIO N/A
- VRCA N/A
- Revenue Growth
- HBIO N/A
- VRCA 47.66
- 52 Week Low
- HBIO $0.56
- VRCA $0.39
- 52 Week High
- HBIO $4.70
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- HBIO 22.38
- VRCA 30.67
- Support Level
- HBIO $0.56
- VRCA $0.39
- Resistance Level
- HBIO $0.63
- VRCA $0.66
- Average True Range (ATR)
- HBIO 0.06
- VRCA 0.07
- MACD
- HBIO 0.02
- VRCA -0.01
- Stochastic Oscillator
- HBIO 3.00
- VRCA 16.87
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.